ClinicalTrials.gov record
Recruiting Early Phase 1 Interventional

Simvastatin Treatment to Improve Patient-reported Outcomes in Patients With Chronic Pancreatitis

ClinicalTrials.gov ID: NCT05771675

Public ClinicalTrials.gov record NCT05771675. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 3:15 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT05771675
Recruitment status
Recruiting
Study type
Interventional
Phase
Early Phase 1
Lead sponsor
Cedars-Sinai Medical Center
Other
Enrollment
90 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • Simvastatin Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 23, 2024
Primary completion
Nov 30, 2026
Completion
May 31, 2027
Last update posted
Feb 26, 2026

2024 – 2027

United States locations

U.S. sites
5
U.S. states
3
U.S. cities
4
Facility City State ZIP Site status
University of Southern California Los Angeles California 90033 Recruiting
Cedars-Sinai Medical Center Los Angeles California 90048 Recruiting
Stanford University Stanford California 94305 Recruiting
Ohio State University Columbus Ohio 43210 Recruiting
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05771675, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 26, 2026 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05771675 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →